compound introduction
Cyclo(RADfK) is a selective α(v)β(3) integrin ligand that has been extensively used for research, therapy, and diagnosis of neoangiogenesis. In Vitro Cyclo(RADfK) is a negative control for the cyclo (-RGDfK-), the RGD peptide. RGD peptides are modulators of cell adhesion and are recognized by several members of the integrin family. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Form:Solid IC50& Target:Integrin
